Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells

 Abstract

miR-155 is a prominent microRNA (miRNA) that regulates genes involved in immunity and cancer-related pathways. miR-155 is overexpressed in lung cancer, which correlates with poor patient prognosis. It is unclear how miR-155 becomes increased in lung cancers and how this increase contributes to reduced patient survival. Here, we show that hypoxic conditions induce miR-155 expression in lung cancer cells and trigger a corresponding decrease in a validated target, FOXO3A. Furthermore, we find that increased levels of miR-155 radioprotects lung cancer cells, while inhibition of miR-155 radiosensitizes these cells. Moreover, we reveal a therapeutically important link between miR-155 expression, hypoxia, and irradiation by demonstrating that anti-miR-155 molecules also sensitize hypoxic lung cancer cells to irradiation. Our study helps explain how miR-155 becomes elevated in lung cancers, which contain extensive hypoxic microenvironments, and demonstrates that inhibition of miR-155 may have important therapeutic potential as a means to radiosensitize hypoxic lung cancer cells.

Full Text Options
Article
Metrics
 Share
 Full Text
 Info
Pages
908 - 914
doi
10.4161/cbt.12.10.17681
Type
Research Paper
 Metrics
 Cite This Article
 Permissions
 Permissions
 Reprints
Inhibition of hypoxia-induced miR-155 radiosensitizes hypoxic lung cancer cells